Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aveir Dual-Chamber Leadless i2i IDE Study

NCT05252702 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT05252702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05252702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aveir Dual-Chamber Leadless i2i IDE Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2022
Completion date
February 3, 2026
Enrollment
464 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, cardiac pacemaker, artificial, cardiac rhythm disorder